<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr31-2050640620920157">
 <label>31</label>
 <mixed-citation publication-type="other">
  <person-group person-group-type="author">
   <name>
    <surname>Yao</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>M</given-names>
   </name>
  </person-group>, 
  <etal>etÂ al</etal> In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 
  <italic>Clin Infect Dis.</italic> Epub ahead of print 9 March 
  <year>2020</year>. DOI: 10.1093/cid/ciaa237.
 </mixed-citation>
</ref>
